CME: Special Patient Populations in MS: Utilizing Shared Decision-Making

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Special Patient Populations in MS: Utilizing Shared Decision-Making

Program Information
Special Patient Populations in MS: Utilizing Shared Decision-Making
Learn how to improve access to care for all MS patient populations, including atypical presentations and possible implications for treatments.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Despite the high prevalence of multiple sclerosis (MS) on a national and global scale, research has found that healthcare providers lack proper education in making treatment decisions for patients from different geographic areas, minority groups, and patients with late-onset disease.

    That’s why this activity will discuss the clinical characteristics of these MS patient populations and how those factors can influence treatment decisions. It will also cover how to integrate shared decision-making into practice in addition to interprofessional collaboration between physicians, nurses, and social workers in order to meet patients’ medical needs and overcome their socioeconomic and cultural barriers to treatment.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Vanessa Zimmerman, MSN, RN, MSCN
    Department of Neurology
    University of Pennsylvania
    Philadelphia, PA

    Mrs. Zimmerman has nothing to disclose. 

    Clyde E. Markowitz, MD
    Director, Multiple Sclerosis Center
    Associate Professor of Neurology
    University of Pennsylvania
    Philadelphia, PA 

    Dr. Markowitz receives consulting fees from Bayer, Biogen, EMD-Serono, Genzyme/Sanofi, Genentech/Roche, Novartis, and Teva.

    Reviewers/Content Planners/Authors:

    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Nick Lombardi has ownership interest with Vertex Pharmaceuticals.
    • Brian P. McDonough, MD, FAAFP has nothing to disclose.
    • Ashley Rosenthal has nothing to disclose.
    • The PIM planners and managers have nothing to disclose.
  • Learning Objectives

    The goal of this activity is to enable effective collaboration and communication between the members of the professional teams who care for patients with multiple sclerosis. After participating in this educational activity, participants should be better able to:

    • Describe how the clinical characteristics of multiple sclerosis patient populations, including patients from different geographic areas, minority groups, or patients with late-onset disease, can influence treatment decisions.
    • Integrate shared decision making into their practice to overcome barriers to treatment, including educational, cultural, and socio-economic factors.
    • Develop a routine for interprofessional collaboration between physicians, nurses, and social workers to meet the medical needs of minority patients and to overcome their socioeconomic and cultural barriers to treatment.
  • Target Audience

    This activity is designed to meet the educational needs of MDs, nurses, nurse practitioners, physician assistants and social workers and other members of the interprofessional team who are involved in the management of patients with multiple sclerosis.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Joint Accreditation Statement

    In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The Omnia-Prova Education Collaborative.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is .4 contact hours. 

    If you have any questions regarding the continuing nursing accreditation of this activity, please contact Postgraduate Institute for Medicine (

    Media: Internet 

  • Providers


    Prova Education, designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.  

  • Commercial Support

    This activity is supported by independent educational grants from Biogen and Genentech.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio


Programs 12/9/19

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.